搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Vibrio cholerae serotype O1 50S ribosomal protein L19 (rplS) CSB-YP398425VEY
CSB-EP398425VEY
CSB-BP398425VEY
CSB-MP398425VEY
CSB-EP398425VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Ribosome maturation factor RimM (rimM) CSB-YP398426VEY
CSB-EP398426VEY
CSB-BP398426VEY
CSB-MP398426VEY
CSB-EP398426VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Alanine--tRNA ligase (alaS), partial CSB-YP398427VEY
CSB-EP398427VEY
CSB-BP398427VEY
CSB-MP398427VEY
CSB-EP398427VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 tRNA pseudouridine synthase D (truD) CSB-YP398428VEY
CSB-EP398428VEY
CSB-BP398428VEY
CSB-MP398428VEY
CSB-EP398428VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Iron-regulated outer membrane virulence protein (irgA), partial CSB-YP398429VEY
CSB-EP398429VEY
CSB-BP398429VEY
CSB-MP398429VEY
CSB-EP398429VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Putative Holliday junction resolvase (VC0395_A0018, VC395_0510) CSB-YP398430VEY
CSB-EP398430VEY
CSB-BP398430VEY
CSB-MP398430VEY
CSB-EP398430VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae 50S ribosomal protein L33 (rpmG) CSB-YP398431FDT
CSB-EP398431FDT
CSB-BP398431FDT
CSB-MP398431FDT
CSB-EP398431FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae UPF0246 protein Fjoh_4905 (Fjoh_4905) CSB-YP398432FDT
CSB-EP398432FDT
CSB-BP398432FDT
CSB-MP398432FDT
CSB-EP398432FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Urease subunit alpha (ureC), partial CSB-YP398433FDT
CSB-EP398433FDT
CSB-BP398433FDT
CSB-MP398433FDT
CSB-EP398433FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Probable molybdopterin-guanine dinucleotide biosynthesis protein A (mobA) CSB-YP398434FDT
CSB-EP398434FDT
CSB-BP398434FDT
CSB-MP398434FDT
CSB-EP398434FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Na (+)/H (+) antiporter nhaA 2, partial CSB-YP398435FDT
CSB-EP398435FDT
CSB-BP398435FDT
CSB-MP398435FDT
CSB-EP398435FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Catalase-peroxidase (katG), partial CSB-YP398436FDT
CSB-EP398436FDT
CSB-BP398436FDT
CSB-MP398436FDT
CSB-EP398436FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae 50S ribosomal protein L9 (rplI) CSB-YP398437FDT
CSB-EP398437FDT
CSB-BP398437FDT
CSB-MP398437FDT
CSB-EP398437FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae DNA ligase (ligA), partial CSB-YP398438FDT
CSB-EP398438FDT
CSB-BP398438FDT
CSB-MP398438FDT
CSB-EP398438FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP398439FDT
CSB-EP398439FDT
CSB-BP398439FDT
CSB-MP398439FDT
CSB-EP398439FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae UPF0061 protein Fjoh_2793 (Fjoh_2793), partial CSB-YP398440FDT
CSB-EP398440FDT
CSB-BP398440FDT
CSB-MP398440FDT
CSB-EP398440FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Cytidylate kinase (cmk) CSB-YP398441FDT
CSB-EP398441FDT
CSB-BP398441FDT
CSB-MP398441FDT
CSB-EP398441FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Probable transcriptional regulatory protein Fjoh_2560 (Fjoh_2560) CSB-YP398442FDT
CSB-EP398442FDT
CSB-BP398442FDT
CSB-MP398442FDT
CSB-EP398442FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae Ribosomal RNA large subunit methyltransferase F (rlmF) CSB-YP398443FDT
CSB-EP398443FDT
CSB-BP398443FDT
CSB-MP398443FDT
CSB-EP398443FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flavobacterium johnsoniae 50S ribosomal protein L1 (rplA) CSB-YP398444FDT
CSB-EP398444FDT
CSB-BP398444FDT
CSB-MP398444FDT
CSB-EP398444FDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>